April 28, 2022
CLEVELAND, Ohio – Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2022 class of Harrington Scholar-Innovators. The scholar awards will support a diverse set of drug discovery projects including new treatments for pulmonary diseases, COVID-19, multiple cancers, corneal...
Continue ReadingMay 09, 2022
Understanding Alzheimer’s remains the scientific challenge of our generation. Seeing a challenge and unmet need, Alzheimer’s researchers supported by Harrington Discovery Institute are attacking the disease in novel ways, with some early successes. Continue Reading
April 13, 2022
Dr. Tang, Stanford University, Harrington Scholar, is developing patidegib, a therapry that will hopefully be the first topical drug that is safe and efficacious for Basal Cell Carcinoma (BCC) tumors (skin cancer) prevention. Continue Reading
March 24, 2022
2022 Harrington Prize for Innovation in Medicine Recognizes Breakthrough Innovations in the Use of Human Antibodies to Treat COVID-19March 24, 2022, Cleveland, Ohio – The ninth annual Harrington Prize for Innovation in Medicine has been jointly awarded to James E. Crowe, Jr., MD, Director, Vanderbilt Vaccine Center and... Continue Reading
March 07, 2022
In honor of Rare Disease Day 2022, The Oxford-Harrington Rare Disease Centre (OHC) hosted a Rare Disease Day Webinar, Advancing Novel Treatments for Neurological Rare Diseases, on Monday, February 28. The Oxford-Harrington Rare Disease Centre is a partnership between Harrington Discovery Institute at University Hospitals and... Continue Reading
February 23, 2022
February 23, 2022, CLEVELAND, Ohio USA - Harrington Discovery Institute at University Hospitals is now accepting the Letters of Intent for the 2023 Harrington Scholar-Innovator Award for physician-scientists. The award offers successful applicants financial resources and expertise to advance their discoveries toward clinical... Continue Reading
January 24, 2022
Linda and Les Vinney committed $1.25 million to establish the Linda and Les Vinney Scholar Program at Harrington Discovery Institute's Center for Brain Health Medicine, which will support new treatments for patients living with Alzheimer's disease. The gift also creates the Linda and Les Vinney Acceleration Awards, which will... Continue Reading
January 18, 2022
Four Medicines in Clinical Trials and More in the Pipeline When it came to vaccines being trialed to prevent COVID-19, University Hospitals was already at the national forefront of innovations advancing COVID-19 treatments in mid-2020.Now four Scholars at Harrington Discovery Institute at University Hospitals might well be... Continue Reading
January 01, 2022
Harrington Discovery Institute advances scientific breakthroughs, accelerates drug development, and impacts the standard of care. We cure diseases, together. In 2012, a $50 million transformative gift from Ron and Nancy Harrington and their children Jill, Ron, and Lydia Harrington, made possible the vision of Dr. Jonathan... Continue Reading
December 09, 2021
New Orleans, LA – LSU Health New Orleans entered into an exclusive option and license agreement with Takeda Pharmaceutical Company Limited (“Takeda”) granting Takeda the exclusive right to develop further a technology invented at LSU Health New Orleans with the aim to discover potential therapeutics to treat rare... Continue Reading
November 16, 2021
CLEVELAND — In 2020, during the height of the COVID-19 Pandemic, Harrington Discovery Institute at University Hospitals put out a call to scientists around the world: Send us your ideas to battle the coronavirus and we may fund your research.They received three hundred applications.All they needed was a fraction of the money... Continue Reading